Khavinson tetrapeptide investigated for telomere maintenance and circadian regulation.
Typical dose range: 5–10 mg
Frequency: Daily, 10–20 day cycles 1–2 × per year
Route: Subcutaneous
Half-life: Short
Evidence level: Russian clinical
Cycled rather than continuous. Most loyal users run a 10-day course twice a year.